Martin Shkreli is a 32-year-old entrepreneur and company builder. A modern day Horatio Alger story, Shkreli grew up the son of 2 janitors in Sheepshead Bay, Brooklyn, and hustled his way into the hedge fund game.
He is now worth at least $45 million.
Although he made his money betting against the pharmaceutical industry, Shkreli switched to running a drug company in 2012. In August of last year, one of his companies acquired the rights to a drug that treats an infection that effects people with AIDS and other immunodeficiencies.
Over night, the price per pill rose by more than 5000% and Shkreli became the poster child for capitalistic greed.
In December, Shkreli was indicted on securities fraud charges and is now under investigation by Congress and the Federal Trade Commission for price gouging. His time in the spotlight is not over yet.
VICE caught up with him at his midtown apartment to meet the man behind the headlines.